Larvol Delta - BE-VITAL-A-Study-to-Assess-the-Longterm-Safety-Tolerability-and-Efficacy-of-Bimekizumab-in-the-Treatment-of-Subjects-With-Active-Psoriatic-Arthritis

Bimzelx (bimekizumab-bkzx) - UCB

http://clinicaltrials.gov/ct2/show/NCT04009499

Jun 2, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next